The life sciences industry, one of China’s strategic emerging industries, has witnessed tremendous growth during recent years, according to Cushman & Wakefield. China itself has become one of the most important life sciences markets globally.
Shaun Brodie, head of occupier research, Greater China, Cushman & Wakefield, said, “The life sciences industry in China will follow the global trend and continue to innovate in a variety of ways, including digital innovation in medical and pharmaceutical services and the application of artificial intelligence within the whole industry chain. Thus, the industry will continue to drive investment in commercial spaces such as laboratories, office buildings and industrial parks. With the continuous advancement of the industry in general, we are looking forward to life sciences being a catalyst that contributes to a change in the genetics of commercial real estate in China.”
To read the full release,
